Clinical Trials for Prostate Cancer
PHEN’s “Find Your Trial (FYT)” search tool connects patients with actively recruiting prostate cancer clinical trials that can possibly benefit them. The FYT tool has seven easy to use searchable categories to help patients find and review clinicals trials based on where they are on their prostate cancer journey. All trials listed have links to important information, including description, study locations, contacts and more.
All Trials
Find Your Trial
MEVPRO-3 Patient Summary – Metastatic Castration Sensitive
Background Information: Prostate cancer is one of the most common types of cancer. It becomes “metastatic” when it spreads to other parts of the body. Surgery or radiation alone cannot fully treat metastatic prostate cancer. Patients often need hormone therapy. When...
The MEVPRO Clinical Trials: What You Need to Know
The MEVPRO clinical trial program is an investigational prostate cancer treatment option for patients with metastatic prostate cancer. These clinical trials provide patients with the study medicine Mevrometostat, which is taken as tablets twice per day with...
AUA’s Urology Practice Publishes PHEN’s Peer-Reviewed Study: Black Men Not Being Asked to Participate in Prostate Cancer Clinical Trials
The Prostate Health Education Network (PHEN), an organization with a mission to eliminate the African American prostate cancer disparity, announced that its peer-reviewed manuscript titled Identification of Factors Affecting the Accrual of Black Males Into Prostate...
Managing Survivorship Meeting: The Find Your Trial (FYT) Tool Increases Access to Prostate Cancer Clinical Trials
On Wednesday, December 11, 2024, PHEN held a hybrid Managing Survivorship Meeting and Webinar at the Dana-Farber Cancer Institute called Expanding Access to Prostate Cancer Clinical Trials: Introducing the Enhanced “Find Your Trial” (FYT) Tool. PHEN Director of...
PHEN Expands Access for Prostate Cancer Patients to Find Clinical Trials Near Them with New “Find Your Trial” (FYT) Tool
Quincy, MA, December 11, 2024 — The Prostate Health Education Network (PHEN) announces the launch of enhanced PHENTrials.com. This online portal provides prostate cancer patients access to clinical trial information based on their specific diagnoses and locations...
MEVPRO-2 Patient Summary – Metastatic Castration Resistant
Background Information: Prostate cancer, one of the most common types of cancer, becomes metastatic when it spreads to other parts of the body. Surgery or radiation alone cannot fully treat metastatic prostate cancer, so patients often undergo hormone...
Congratulations to our Dr. Crawford whose article “Narrowing the Diversity Gap” in Clinical Trials launched today in USA Today and on Future of Personal Health!
MEVPRO-1 Patient Summary – Metastatic Castration Resistant
Background Information: Prostate cancer, one of the most common types of cancer, becomes metastatic when it spreads to other parts of the body. Surgery or radiation alone cannot fully treat metastatic prostate cancer, so patients often undergo hormone therapy. ...
Omaha-003 Patient Summary – Metastatic Castration Resistant
This clinical trial is for participants who have metastatic castration-resistant prostate cancer (mCRPC) and failed to respond to drugs or surgery to block the testes from making hormones and after treatment with other drugs for prostate cancer. Study of...
PHEN Survivor Network Member Art Cain Beats Prostate Cancer with PANTHER Trial After Attending PHEN Summit
Black men are 70% more likely to become diagnosed with prostate cancer as all other men and more than twice as likely to die from this disease. However, diverse patient enrollment in prostate cancer clinical trials may make a difference in reducing this racial...
Find Your Trial
Low Risk
Intermediate Risk
High Risk
Cancer Recurrence
Non-Metastatic Castration Resistant
Metastatic Castration Sensitive
Metastatic Castration Resistant
This information is for educational purposes only and not intended as medical advice.
Patients should consult their medical doctor for advice and recommendations about specific clinical trials.